Search research articles
お問い合わせ
Search research articles
Search
関連する実験動画
メタアナリシス メタ分析
P Easterbrook
,
J Berlin
Lancet (London, England)
|
April 10, 1993
日本語
まとめ
No abstract available in
PubMed
.
関連する概念動画
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
すべて
12
Same author
6
Same journal
6
Same author
Palliative and supportive care underutilization for patients with locally advanced pancreatic cancer: review of the NCDB.
ESMO gastrointestinal oncology
·
2026
Same author
Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer.
ESMO open
·
2025
Same author
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022.
ESMO open
·
2023
Same author
Need for integration of hepatitis C (HCV) services in community-based settings for people who inject drugs: results from a global values and preferences survey.
Harm reduction journal
·
2023
Same author
Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology
·
2016
Same author
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology
·
2016
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)
·
2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)
·
2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)
·
2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)
·
2026
Same journal
Research priorities for characterising Bundibugyo virus.
Lancet (London, England)
·
2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)
·
2026
関連記事をすべて見る